Opportunity
My Florida Marketplace #EXP2670
Procurement of Sebia Reagents and Services for Newborn Hemoglobin Screening Analyzer
Posted
May 13, 2026
Respond By
June 03, 2026
Identifier
EXP2670
NAICS
423490
This procurement supports the Florida Department of Health's newborn screening program by acquiring specialized reagents and services for hemoglobin analysis: - Government Buyer: - Florida Department of Health (DOH), Bureau of Public Health Laboratories (BPHL), Newborn Screening Unit - OEM Highlight: - Sebia, Inc. is the sole manufacturer and distributor of the CAPILLARS 3 DBS automated analyzer and its proprietary reagents and consumables - Products and Services Requested: - Reagents, controls, calibrators, and consumables for the FDA-approved CAPILLARS 3 DBS automated analyzer - Associated services for operation and maintenance of the analyzer - All products are specifically for qualitative screening of normal and abnormal hemoglobin in newborn dried blood samples - Unique Requirements: - Only Sebia reagents and consumables are compatible and FDA-approved for use with the CAPILLARS 3 DBS analyzer - Ensures standardized, reliable, and regulatory-compliant newborn screening - Estimated Contract Value: - $2,695,571 over three years - Place of Performance: - Bureau of Public Health Laboratories, 4052 Bald Cypress Way, Tallahassee, FL 32399
Description
The Department of Health, Bureau of Public Health Laboratories (BPHL), Newborn Screening Unit, seeks to purchase reagents, controls, calibrators, consumables, and services for the FDA-approved CAPILLARS 3 DBS automated analyzer. These items are used for qualitative screening to detect normal and abnormal hemoglobin using dry blood from newborns. The procurement aims to speed up dry blood sample testing and improve accuracy for early screening of genetic and inheritable disorders, ensuring reliable results for clinical intervention. The purchase is requested as a single source from Sebia Inc.